No abstract available
MeSH terms
-
Arteriosclerosis Obliterans / drug therapy
-
Fibrinolytic Agents / therapeutic use*
-
Humans
-
Myocardial Infarction / drug therapy
-
Pulmonary Embolism / drug therapy
-
Streptokinase / adverse effects
-
Streptokinase / therapeutic use
-
Thrombophlebitis / drug therapy
-
Urokinase-Type Plasminogen Activator / adverse effects
-
Urokinase-Type Plasminogen Activator / therapeutic use
Substances
-
Fibrinolytic Agents
-
Streptokinase
-
Urokinase-Type Plasminogen Activator